Quarterly Result14 May 2026, 05:51 pm
Mangalam Drugs: Audited Financial Results for FY26
AI Summary
Mangalam Drugs & Organics Ltd declared audited standalone and consolidated financial results for the year ended March 31, 2026, following a board meeting held on May 14, 2026. The statutory auditors have issued an unmodified opinion on the audited financial results. The board meeting commenced at 12:30 P.M. and concluded at 3:45 P.M.
Key Highlights
- Audited standalone and consolidated financial results for FY26 approved.
- Auditors issued an unmodified opinion on the financial results.
- Board meeting held on May 14, 2026, to approve the results.
- Results are pursuant to Regulation 33 of the SEBI LODR Regulations.
Price Impact
More from MANGALAM